- Home
- DOO vs GRFS Comparison
DOO vs GRFS Comparison
Compare DOO & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOO | GRFS |
|---|---|---|
| Founded | 1937 | 1940 |
| Country | Canada | Spain |
| Employees | N/A | 25247 |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DOO | GRFS |
|---|---|---|
| Price | $65.96 | $7.49 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $75.00 | $10.15 |
| AVG Volume (30 Days) | 204.0K | ★ 817.0K |
| Earning Date | 03-26-2026 | 07-28-2022 |
| Dividend Yield | 0.92% | ★ 1.87% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.55 | $5.33 |
| Revenue Next Year | $5.40 | $6.50 |
| P/E Ratio | $338.95 | ★ $18.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $60.02 | $6.19 |
| 52 Week High | $81.89 | $11.14 |
Technical Indicators
Market Signals| Indicator | DOO | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 43.00 | 30.68 |
| Support Level | $62.57 | N/A |
| Resistance Level | $81.52 | $9.11 |
| Average True Range (ATR) | 2.46 | 0.19 |
| MACD | 0.65 | -0.02 |
| Stochastic Oscillator | 63.93 | 10.80 |
Price Performance
Historical ComparisonAbout GRFS Grifols S.A.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.